Compounds > fenofibrate

fenofibrate and natriuretic peptide, brain

fenofibrate has been researched along with natriuretic peptide, brain in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (60.00)29.6817
2010's2 (40.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gardner, DG; Liang, F; Wang, F; Zhang, S1
Brigadeau, F; Duriez, P; Fruchart, JC; Gelé, P; Lacroix, D; Marquié, C; Martin-Nizard, F; Staels, B; Torpier, G; Wibaux, M1
Chen, HJ; Chen, JZ; Wang, XX; Yu, M1
Bao, Y; Cai, Y; Huang, H; Lan, T; Le, K; Li, C; Li, R; Liu, P; Moss, J; Shen, X; Wu, X; Xu, S; Zou, J1
Harikrishnan, VS; Ismael, S; Nair, RR; Purushothaman, S1

Other Studies

5 other study(ies) available for fenofibrate and natriuretic peptide, brain

ArticleYear
Peroxisome proliferator activated receptor (PPAR)alpha agonists inhibit hypertrophy of neonatal rat cardiac myocytes.
    Endocrinology, 2003, Volume: 144, Issue:9

    Topics: Animals; Animals, Newborn; Base Sequence; Cell Size; Cells, Cultured; Fenofibrate; Gene Expression; Heart Ventricles; Hypertrophy; Hypoglycemic Agents; Hypolipidemic Agents; Ligands; Molecular Sequence Data; Mutagenesis, Site-Directed; Myocytes, Cardiac; Natriuretic Peptide, Brain; Peroxisome Proliferators; Pyrimidines; Rats; Receptors, Cytoplasmic and Nuclear; Rosiglitazone; Sarcomeres; Thiazoles; Thiazolidinediones; Transcription Factors

2003
The PPARalpha activator fenofibrate slows down the progression of the left ventricular dysfunction in porcine tachycardia-induced cardiomyopathy.
    Journal of cardiovascular pharmacology, 2007, Volume: 49, Issue:6

    Topics: Acyl-CoA Oxidase; Animals; Atrial Natriuretic Factor; Biomarkers; Cardiac Output, Low; Cardiomyopathies; Carnitine O-Palmitoyltransferase; Endothelin-1; Female; Fenofibrate; Myocardium; Natriuretic Peptide, Brain; Oxidative Stress; PPAR alpha; RNA, Messenger; Swine; Tachycardia; Thiobarbituric Acid Reactive Substances; Ventricular Dysfunction, Left

2007
[PPAR alpha activator fenofibrate regressed left ventricular hypertrophy and increased myocardium PPAR alpha expression in spontaneously hypertensive rats].
    Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences, 2007, Volume: 36, Issue:5

    Topics: Animals; Blood Pressure; Blotting, Western; Fenofibrate; Hypertension; Hypertrophy, Left Ventricular; Lipids; Male; Myocardium; Natriuretic Peptide, Brain; PPAR alpha; Random Allocation; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Time Factors; Transcription Factor RelA

2007
PPARα activation inhibits endothelin-1-induced cardiomyocyte hypertrophy by prevention of NFATc4 binding to GATA-4.
    Archives of biochemistry and biophysics, 2012, Feb-01, Volume: 518, Issue:1

    Topics: Animals; Cardiomegaly; Cell Nucleus; Dose-Response Relationship, Drug; Endothelin-1; Fenofibrate; GATA4 Transcription Factor; Gene Expression Regulation; Myocytes, Cardiac; Natriuretic Peptide, Brain; NFATC Transcription Factors; PPAR alpha; Promoter Regions, Genetic; Protein Binding; Rats; Rats, Sprague-Dawley; RNA, Messenger

2012
Ligand specific variation in cardiac response to stimulation of peroxisome proliferator-activated receptor-alpha in spontaneously hypertensive rat.
    Molecular and cellular biochemistry, 2015, Volume: 406, Issue:1-2

    Topics: Acyl-CoA Dehydrogenase; Animals; Blood Pressure; Cardiomegaly; Fenofibrate; Gene Expression; Hypertension; Ligands; Male; Myocardium; Myocytes, Cardiac; Natriuretic Peptide, Brain; Oxidative Stress; PPAR alpha; Procollagen; Rats, Inbred SHR

2015